Established and leading a healthcare consulting firm specializing in specialty biologic procurement, medical supply chain patient advocacy, market access strategies, and clinical trial design optimization. Provide expert consultancy to infusion centers, health systems, pharmaceutical companies, and serve on advisory boards for healthcare organizations.
• Consult for major pharmaceutical companies including Immunovant, Viridian Therapeutics, and Amgen, providing patient insights and market access strategies.
• Serve as Advisory Board Member for Infusion Access Foundation, offering expertise in rare disease community development and health policy.
• Participate in Washington, DC 'Hill Days' with the Autoimmune Association, advocating for policy changes and sharing patient experiences with state legislators.
• Speak and present at industry conferences, including the National Infusion Center Association, on topics related to patient advocacy and access to care.
• Consult with healthca

Led patient engagement initiatives for individuals living with Thyroid Eye Disease.
• Designed and executed specialized workshops for TED patients.
• Developed educational content and interactive sessions to empower patients and improve quality of life.
• Created and implemented strategic social media plans to increase patient engagement and promote health awareness.

Led overall management of the firm's procurement function and strategic sourcing initiatives, overseeing $600M+ in specialty biologics and supplies. Collaborate with C-suite executives to align purchasing objectives with company budget and profit margin goals.
• Secured over $4M in product rebate dollars, boosting quarterly earnings (Q2 2024) by 7.8%.
• Developed and executed procurement strategic sourcing plans in collaboration with Chief Trade and Asset Officer and Chief Financial Officer.
• Implemented innovative strategies to optimize supply chain efficiency and cost-effectiveness.

Rapid advancement through multiple roles, showcasing exceptional leadership and strategic acumen in the specialty infusion sector. Progressed from Senior Account Manager to Strategic Account Representative, then to Strategic Business Development Manager, and finally to Senior Strategic Business Advisor. Demonstrated consistent success in sales team leadership, portfolio management, and market expansion strategies.
• Acquired $700M+ in new client contracted business in 2023, contributing to 55% YOY growth in infusion center segment.
• Implemented innovative sales strategies resulting in 25% increase in client retention rate.
• Secured $470M in new contracted client business, expanding infusion market share by 30%.
• Engaged corporate initiatives reducing total medical expenses by up to 56% while boosting company's EBITDA earnings.
• Acquired $10M key account, boosting infusion portfolio earnings by 31.6% YOY.
• Developed Tableau data analytics tool for client drug rebate tracking.

Led high performing timeshare sales team and increased closing ratio by 39.8%

Increased sales of luxury eye wear brands by 92.3% YOY